Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Metformin × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3 Sarcoma 1 Gastrointestinal 1

Conditions

Sarcoma, Myeloid 1 Sarcoma, Ewing 1 Sarcoma 1 Osteosarcoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Dendritic Cell Sarcoma, Interdigitating 1 Chondrosarcoma 1 Cholangiocarcinoma 1

Interventions

Temozolomide 51 Bevacizumab 23 Radiotherapy 16 Magnetic Resonance Spectroscopy 16 Irinotecan 15 Carmustine 12 Erlotinib Hydrochloride 10 Carboplatin 8 Surgical Procedures, Operative 6 O(6)-benzylguanine 6 Imatinib Mesylate 6 Filgrastim 6 Cyclophosphamide 6 Biopsy 6 sargramostim 5 aldesleukin 5 X-Rays 5 Thalidomide 5 Phantoms, Imaging 5 Chemotherapy, Adjuvant 5 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 5 temsirolimus 4 Topotecan 4 Specimen Handling 4 Sirolimus 4 Radiation 4 Peripheral Blood Stem Cell Transplantation 4 Nuclear Medicine Department, Hospital 4 Etoposide 4 Cisplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02496741 2020-01-09

MACIST

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Completed

CNSGastrointestinalSarcoma

Chondrosarcoma, Glioma, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡